カテゴリ： FactMR, 世界, 医療/バイオ

光前臨床イメージングのグローバル市場2023～2033：生物発光/蛍光イメージングシステム、スタンドアロン型蛍光イメージングシステム、光学＋X線／光学＋CT

■ 英語タイトル：Optical Preclinical Imaging Market Analysis By Reagent (Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents), By Application (Research & Development, Drug Discovery), By End User (Pharma & Biotech Companies, Research Institutes), By Modality & Region - Global Market Insights 2023 to 2033

調査会社FactMR社が発行したリサーチレポート（データ管理コード：FACT23AP099）■ 発行会社/調査会社：FactMR
■ 商品コード：FACT23AP099
■ 発行日：2023年2月16日
   最新版(2025年又は2026年)はお問い合わせください。
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：約170
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）見積依頼/購入/質問フォーム
Global Sie License（同一拠点内共有可）見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※FactMR社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[光前臨床イメージングのグローバル市場2023～2033：生物発光/蛍光イメージングシステム、スタンドアロン型蛍光イメージングシステム、光学＋X線／光学＋CT]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Fact.MR社による最新調査レポートでは、世界の光前臨床イメージング市場について2023年度から2033年度までの10年間にわたる市場規模予測を掲載しています。当書では、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症の影響分析、市場背景、価格分析、モダリティ別（生物発光/蛍光イメージングシステム、スタンドアロン型蛍光イメージングシステム、光学＋X線/光学＋CT）分析、試薬別（生物発光イメージング試薬、蛍光イメージング試薬）分析、用途別（研究＆開発、創薬）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、研究機関）分析、地域別（北米、ヨーロッパ、東アジア、南アジア、中南米、中東/アフリカ、オセアニア）分析、競争状況、競争分析、分析フレームワークの定義、情報源・参考文献などの項目を掲載しています。なお、当市場の主要企業には、BioTek Instruments, Inc.、Bruker Corporation、Fujifilm Holdings Corporationなどが含まれています。
・エグゼクティブサマリー
・市場概要
・新型コロナウイルス感染症の影響分析
・市場背景
・価格分析
・世界の光前臨床イメージング市場規模：モダリティ別
　- 生物発光/蛍光イメージングシステムの市場規模
　- スタンドアロン型蛍光イメージングシステムの市場規模
　- 光学＋X線/光学＋CTの市場規模
・世界の光前臨床イメージング市場規模：試薬別
　- 生物発光イメージング試薬の市場規模
　- 蛍光イメージング試薬の市場規模
・世界の光前臨床イメージング市場規模：用途別
　- 研究＆開発における市場規模
　- 創薬における市場規模
・世界の光前臨床イメージング市場規模：エンドユーザー別
　- 製薬＆バイオテクノロジー企業における市場規模
　- 研究機関における市場規模
・世界の光前臨床イメージング市場規模：地域別
　- 北米の光前臨床イメージング市場規模
　- 中南米の光前臨床イメージング市場規模
　- ヨーロッパの光前臨床イメージング市場規模
　- 東アジアの光前臨床イメージング市場規模
　- 南アジア＆オセアニアの光前臨床イメージング市場規模
　- 中東/アフリカの光前臨床イメージング市場規模
・競争状況
・競争分析
・分析フレームワークの定義
・情報源・参考文献

本書は、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などのエッセンスを含む企業情報を含んでいます。企業のプレゼンスは、すべての著名な市場参入者についてマッピングされ、マトリックスを通して提示されます。したがって、購読者に実用的なインサイトを提供し、熟考して市場状況などを提示し、光前臨床イメージングにおける競争レベルを予想するのに有効です。

Optical Preclinical Imaging Market – Scope of Report

A recent study by Fact.MR on the optical preclinical imaging market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering optical preclinical imaging.

The study also provides the dynamics responsible for influencing the future status of the optical preclinical imaging market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the optical preclinical imaging market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of optical preclinical imaging across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of optical preclinical imaging during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for optical preclinical imaging are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global optical preclinical imaging market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the optical preclinical imaging market during the forecast period.

Country-specific valuation on demand for optical preclinical imaging has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of optical preclinical imaging, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering optical preclinical imaging has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the optical preclinical imaging domain.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Executive Summary

    1.1. Key Findings

        1.1.1. Overall Market

        1.1.2. Segment Overview

        1.1.3. Regional Overview

        1.1.4. Competitor’s Focus

        1.1.5. Consumer’s Perception

    1.2. Summary of Statistics

    1.3. Market Characteristics and Attributes

2. Market Overview

    2.1. Introduction and Definition

    2.2. Research Scope

3. COVID 19 Impact Assessment

    3.1. Demand in Market

        3.1.1. Global Market Quarterly Market Value Analysis (US$ Mn), 2022

        3.1.2. Global Market Value Y-o-Y Growth Pre and Post Crisis Projection

        3.1.3. Global Market Recalibrated Growth Projection (US$ Mn)

    3.2. Market Shrink and Recovery Trend Assessment, by Region

    3.3. Market Recalibrated Market and Growth Assessment, by Region

4. Market Background

    4.1. Country wise Market Attractiveness Index

    4.2. Market Scenario-based Forecast

    4.3. Value Chain Analysis

        4.3.1. List of Manufacturers

        4.3.2. List of Online Retailers

        4.3.3. List of End Users

    4.4. Investment Feasibility Assessment

        4.4.1. Investment Feasibility for Market

    4.5. Porter’s Five Forces Analysis

        4.5.1. Bargaining Power of Buyers

        4.5.2. Bargaining Power of Suppliers

        4.5.3. Threat of Substitute Reagents

        4.5.4. Threat of New Entrants

        4.5.5. Intensity of Rivalry

        4.5.6. 5 Forces Acting Upon Market

    4.6. PESTEL Analysis

    4.7. Forecast Factors

        4.7.1. Increasing Government Regulations

        4.7.2. Expansion of Industry

        4.7.3. Compliance to Insurance Regulations

        4.7.4. Advancements in Market

        4.7.5. Increasing Global Temperature

        4.7.6. Technological Advancements

    4.8. Market Dynamics

        4.8.1. Market Drivers

        4.8.2. Market Restraints

        4.8.3. Opportunity Windows

        4.8.4. Key Trends

5. Global Market Pricing Analysis

    5.1. Price Point Assessment

        5.1.1. Weighted Average Pricing (2022), by Region

        5.1.2. Key Factors Influencing Pricing

        5.1.3. Price Benchmark by Region

        5.1.4. Price Benchmark by Modality

6. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033)

    6.1. Market Overview

    6.2. Introduction to Market Statistics

        6.2.1. Global Market Volume (Units)

        6.2.2. Global Market Value (US$ Mn)

        6.2.3. Global Cumulative Historical Market and Absolute $ Opportunity

    6.3. Y-o-Y Growth and Incremental Opportunity

    6.4. Absolute Dollar Historical Market and Absolute Dollar Opportunity

7. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Modality

    7.1. Introduction

        7.1.1. Modality Definition

            7.1.1.1. Bioluminescence/Fluorescence Imaging Systems

            7.1.1.2. Standalone Fluorescence Imaging Systems

            7.1.1.3. Optical + X-ray/Optical + CT

        7.1.2. Market Key Findings, by Modality

            7.1.2.1. Absolute $ Opportunity (2023 to 2033)

            7.1.2.2. Market Share and BPS Analysis

            7.1.2.3. Y-o-Y Growth Projections

            7.1.2.4. Market Attractiveness Analysis

    7.2. Global Market Regional Market Share Comparison, by Modality

8. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Reagent

    8.1. Introduction

        8.1.1. Reagent Definition

            8.1.1.1. Bioluminescent Imaging Reagents

            8.1.1.2. Fluorescent Imaging Reagents

        8.1.2. Market Key Findings, by Reagent

            8.1.2.1. Absolute $ Opportunity (2023 to 2033)

            8.1.2.2. Market Share and BPS Analysis

            8.1.2.3. Y-o-Y Growth Projections

            8.1.2.4. Market Attractiveness Analysis

    8.2. Global Market Regional Market Share Comparison, by Reagent

9. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Application

    9.1. Introduction

        9.1.1. Application Definition

            9.1.1.1. Research & Development

            9.1.1.2. Drug Discovery

        9.1.2. Market Key Findings, by Application

            9.1.2.1. Absolute $ Opportunity (2023 to 2033)

            9.1.2.2. Market Share and BPS Analysis

            9.1.2.3. Y-o-Y Growth Projections

            9.1.2.4. Market Attractiveness Analysis

    9.2. Global Market Regional Market Share Comparison, by Application

10. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by End User

    10.1. Introduction

        10.1.1. End User Definition

            10.1.1.1. Pharma & Biotech Companies

            10.1.1.2. Research Institutes

        10.1.2. Market Key Findings, by End User

            10.1.2.1. Absolute $ Opportunity (2023 to 2033)

            10.1.2.2. Market Share and BPS Analysis

            10.1.2.3. Y-o-Y Growth Projections

            10.1.2.4. Market Attractiveness Analysis

    10.2. Global Market Regional Market Share Comparison, by End User

11. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Region

    11.1. Introduction

        11.1.1. Regional Coverage

            11.1.1.1. North America

            11.1.1.2. Europe

            11.1.1.3. East Asia

            11.1.1.4. South Asia

            11.1.1.5. Latin America

            11.1.1.6. Middle East & Africa (MEA)

            11.1.1.7. Oceania

        11.1.2. Market Key Findings, by Region

            11.1.2.1. Absolute $ Opportunity (2023 to 2033)

            11.1.2.2. Market Share and BPS Analysis

            11.1.2.3. Y-o-Y Growth Projections

            11.1.2.4. Market Attractiveness Analysis

    11.2. Global Market Regional Market Share Comparison, by Region

12. North America Market Analysis and Forecast

    12.1. Overview

        12.1.1. North America Share in Global Market

    12.2. Market Value & Volume Forecast and Analysis

        12.2.1. By Country

            12.2.1.1. United States

            12.2.1.2. Canada

        12.2.2. By Modality

        12.2.3. By Reagent

        12.2.4. By Application

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

            12.3.1.1. United States

            12.3.1.2. Canada

        12.3.2. By Modality

        12.3.3. By Reagent

        12.3.4. By Application

        12.3.5. By End User

    12.4. Y-o-Y Growth Comparison

13. Europe Market Analysis and Forecast

    13.1. Overview

        13.1.1. Europe Share in Global Market

    13.2. Market Value & Volume Forecast and Analysis

        13.2.1. By Country

            13.2.1.1. Germany

            13.2.1.2. United Kingdom

            13.2.1.3. France

            13.2.1.4. Russia

            13.2.1.5. Spain

            13.2.1.6. Italy

            13.2.1.7. Rest of Europe

        13.2.2. By Modality

        13.2.3. By Reagent

        13.2.4. By Application

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. United Kingdom

            13.3.1.3. France

            13.3.1.4. Russia

            13.3.1.5. Spain

            13.3.1.6. Italy

            13.3.1.7. Rest of Europe

        13.3.2. By Modality

        13.3.3. By Reagent

        13.3.4. By Application

        13.3.5. By End User

    13.4. Y-o-Y Growth Comparison

14. East Asia Market Analysis and Forecast

    14.1. Overview

        14.1.1. East Asia Share in Global Market

    14.2. Market Value & Volume Forecast and Analysis

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Modality

        14.2.3. By Reagent

        14.2.4. By Application

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

        14.3.2. By Modality

        14.3.3. By Reagent

        14.3.4. By Application

        14.3.5. By End User

    14.4. Y-o-Y Growth Comparison

15. South Asia Market Analysis and Forecast

    15.1. Overview

        15.1.1. South Asia Share in Global Market

    15.2. Market Value & Volume Forecast and Analysis

        15.2.1. By Country

            15.2.1.1. India

            15.2.1.2. Singapore

            15.2.1.3. Indonesia

            15.2.1.4. Thailand

            15.2.1.5. Rest of South Asia

        15.2.2. By Modality

        15.2.3. By Reagent

        15.2.4. By Application

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Singapore

            15.3.1.3. Indonesia

            15.3.1.4. Thailand

            15.3.1.5. Rest of South Asia

        15.3.2. By Modality

        15.3.3. By Reagent

        15.3.4. By Application

        15.3.5. By End User

    15.4. Y-o-Y Growth Comparison

16. Latin America Market Analysis and Forecast

    16.1. Overview

        16.1.1. Latin America Share in Global Market

    16.2. Market Value & Volume Forecast and Analysis

        16.2.1. By Country

            16.2.1.1. Brazil

            16.2.1.2. Mexico

            16.2.1.3. Rest of LATAM

        16.2.2. By Modality

        16.2.3. By Reagent

        16.2.4. By Application

        16.2.5. By End User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Rest of LATAM

        16.3.2. By Modality

        16.3.3. By Reagent

        16.3.4. By Application

        16.3.5. By End User

    16.4. Y-o-Y Growth Comparison

17. Middle East & Africa Market Analysis and Forecast

    17.1. Overview

        17.1.1. Middle East & Africa Share in Global Market

    17.2. Market Value & Volume Forecast and Analysis

        17.2.1. By Country

            17.2.1.1. Turkey

            17.2.1.2. GCC Countries

            17.2.1.3. South Asia

            17.2.1.4. Rest of MEA

        17.2.2. By Modality

        17.2.3. By Reagent

        17.2.4. By Application

        17.2.5. By End User

    17.3. Market Attractiveness Analysis

        17.3.1. By Country

            17.3.1.1. Turkey

            17.3.1.2. GCC Countries

            17.3.1.3. South Asia

            17.3.1.4. Rest of MEA

        17.3.2. By Modality

        17.3.3. By Reagent

        17.3.4. By Application

        17.3.5. By End User

    17.4. Y-o-Y Growth Comparison

18. Oceania Market Analysis and Forecast

    18.1. Overview

        18.1.1. Oceania Share in Global Market

    18.2. Market Value & Volume Forecast and Analysis

        18.2.1. By Country

            18.2.1.1. Australia

            18.2.1.2. New Zealand

        18.2.2. By Modality

        18.2.3. By Reagent

        18.2.4. By Application

        18.2.5. By End User

    18.3. Market Attractiveness Analysis

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Modality

        18.3.3. By Reagent

        18.3.4. By Application

        18.3.5. By End User

    18.4. Y-o-Y Growth Comparison

19. Global Market Analysis Key Countries

    19.1. US

        19.1.1. Share of North American Market

        19.1.2. Market Share, by Modality, 2022

        19.1.3. Market Share, by Reagent, 2022

        19.1.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.1.5. Market Share, by End User, 2022

    19.2. Canada

        19.2.1. Share of North American Market

        19.2.2. Market Share, by Modality, 2022

        19.2.3. Market Share, by Reagent, 2022

        19.2.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.2.5. Market Share, by End User, 2022

    19.3. Germany

        19.3.1. Share of European Market

        19.3.2. Market Share, by Modality, 2022

        19.3.3. Market Share, by Reagent, 2022

        19.3.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.3.5. Market Share, by End User, 2022

    19.4. United Kingdom

        19.4.1. Share of European Market

        19.4.2. Market Share, by Modality, 2022

        19.4.3. Market Share, by Reagent, 2022

        19.4.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.4.5. Market Share, by End User, 2022

    19.5. France

        19.5.1. Share of European Market

        19.5.2. Market Share, by Modality, 2022

        19.5.3. Market Share, by Reagent, 2022

        19.5.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.5.5. Market Share, by End User, 2022

    19.6. Russia

        19.6.1. Share of European Market

        19.6.2. Market Share, by Modality, 2022

        19.6.3. Market Share, by Reagent, 2022

        19.6.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.6.5. Market Share, by End User, 2022

    19.7. Spain

        19.7.1. Share of European Market

        19.7.2. Market Share, by Modality, 2022

        19.7.3. Market Share, by Reagent, 2022

        19.7.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.7.5. Market Share, by End User, 2022

    19.8. Italy

        19.8.1. Share of European Market

        19.8.2. Market Share, by Modality, 2022

        19.8.3. Market Share, by Reagent, 2022

        19.8.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.8.5. Market Share, by End User, 2022

    19.9. China

        19.9.1. Share of East Asian Market

        19.9.2. Market Share, by Modality, 2022

        19.9.3. Market Share, by Reagent, 2022

        19.9.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.9.5. Market Share, by End User, 2022

    19.10. Japan

        19.10.1. Share of East Asian Market

        19.10.2. Market Share, by Modality, 2022

        19.10.3. Market Share, by Reagent, 2022

        19.10.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.10.5. Market Share, by End User, 2022

    19.11. South Korea

        19.11.1. Share of East Asian Market

        19.11.2. Market Share, by Modality, 2022

        19.11.3. Market Share, by Reagent, 2022

        19.11.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.11.5. Market Share, by End User, 2022

    19.12. India

        19.12.1. Share of South Asian Market

        19.12.2. Market Share, by Modality, 2022

        19.12.3. Market Share, by Reagent, 2022

        19.12.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.12.5. Market Share, by End User, 2022

    19.13. Singapore

        19.13.1. Share of South Asian Market

        19.13.2. Market Share, by Modality, 2022

        19.13.3. Market Share, by Reagent, 2022

        19.13.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.13.5. Market Share, by End User, 2022

    19.14. Indonesia

        19.14.1. Share of South Asian Market

        19.14.2. Market Share, by Modality, 2022

        19.14.3. Market Share, by Reagent, 2022

        19.14.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.14.5. Market Share, by End User, 2022

    19.15. Thailand

        19.1.15.1. Share of South Asian Market

        19.1.15.2. Market Share, by Modality, 2022

        19.1.15.3. Market Share, by Reagent, 2022

        19.1.15.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.1.15.5. Market Share, by End User, 2022

    19.16. Brazil

        19.16.1. Share of Latin American Market

        19.16.2. Market Share, by Modality, 2022

        19.16.3. Market Share, by Reagent, 2022

        19.16.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.16.5. Market Share, by End User, 2022

    19.17. Mexico

        19.17.1. Share of Latin American Market

        19.17.2. Market Share, by Modality, 2022

        19.17.3. Market Share, by Reagent, 2022

        19.17.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.17.5. Market Share, by End User, 2022

    19.18. Turkey

        19.18.1. Share of MEA Market

        19.18.2. Market Share, by Modality, 2022

        19.18.3. Market Share, by Reagent, 2022

        19.18.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.18.5. Market Share, by End User, 2022

    19.19. GCC Countries

        19.19.1. Share of MEA Market

        19.19.2. Market Share, by Modality, 2022

        19.19.3. Market Share, by Reagent, 2022

        19.19.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.19.5. Market Share, by End User, 2022

    19.20. South Africa

        19.20.1. Share of MEA Market

        19.20.2. Market Share, by Modality, 2022

        19.20.3. Market Share, by Reagent, 2022

        19.20.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.20.5. Market Share, by End User, 2022

    19.21. Australia

        19.21.1. Share of Oceania Market

        19.21.2. Market Share, by Modality, 2022

        19.21.3. Market Share, by Reagent, 2022

        19.21.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.21.5. Market Share, by End User, 2022

    19.22. New Zealand

        19.22.1. Share of Oceania Market

        19.22.2. Market Share, by Modality, 2022

        19.22.3. Market Share, by Reagent, 2022

        19.22.4. Market Value (US$ Mn) and Forecast 2023 to 2033

        19.22.5. Market Share, by End User, 2022

20. Competition Landscape

    20.1. Global Market Competition Dashboard

    20.2. Global Market Tier Structure

        20.2.1. Market Structure in 2022

        20.2.2. Anticipated Market Structure in 2033

    20.3. Global Market Share Analysis

21. Competition Analysis

    21.1. BioTek Instruments, Inc.

        21.1.1. Company Overview

        21.1.2. Reagent Portfolio

        21.1.3. Key Strategies

        21.1.4. Regional Presence

        21.1.5. Key Developments

        21.1.6. SWOT Analysis

    21.2. Bruker Corporation

        21.2.1. Company Overview

        21.2.2. Reagent Portfolio

        21.2.3. Key Strategies

        21.2.4. Regional Presence

        21.2.5. Key Developments

        21.2.6. SWOT Analysis

    21.3. Fujifilm Holdings Corporation

        21.3.1. Company Overview

        21.3.2. Reagent Portfolio

        21.3.3. Key Strategies

        21.3.4. Regional Presence

        21.3.5. Key Developments

        21.3.6. SWOT Analysis

    21.4. Magnetic Insight, Inc.

        21.4.1. Company Overview

        21.4.2. Reagent Portfolio

        21.4.3. Key Strategies

        21.4.4. Regional Presence

        21.4.5. Key Developments

        21.4.6. SWOT Analysis

    21.5. MBF Bioscience

        21.5.1. Company Overview

        21.5.2. Reagent Portfolio

        21.5.3. Key Strategies

        21.5.4. Regional Presence

        21.5.5. Key Developments

        21.5.6. SWOT Analysis

    21.6. Mediso Ltd.

        21.6.1. Company Overview

        21.6.2. Reagent Portfolio

        21.6.3. Key Strategies

        21.6.4. Regional Presence

        21.6.5. Key Developments

        21.6.6. SWOT Analysis

    21.7. MILabs B.V.

        21.7.1. Company Overview

        21.7.2. Reagent Portfolio

        21.7.3. Key Strategies

        21.7.4. Regional Presence

        21.7.5. Key Developments

        21.7.6. SWOT Analysis

    21.8. Miltenyi Biotec

        21.8.1. Company Overview

        21.8.2. Reagent Portfolio

        21.8.3. Key Strategies

        21.8.4. Regional Presence

        21.8.5. Key Developments

        21.8.6. SWOT Analysis

    21.9. MR Solutions

        21.9.1. Company Overview

        21.9.2. Reagent Portfolio

        21.9.3. Key Strategies

        21.9.4. Regional Presence

        21.9.5. Key Developments

        21.9.6. SWOT Analysis

    21.10. PerkinElmer, Inc.

        21.10.1. Company Overview

        21.10.2. Reagent Portfolio

        21.10.3. Key Strategies

        21.10.4. Regional Presence

        21.10.5. Key Developments

        21.10.6. SWOT Analysis

    21.11. TriFoil Imaging

        21.11.1. Company Overview

        21.11.2. Reagent Portfolio

        21.11.3. Key Strategies

        21.11.4. Regional Presence

        21.11.5. Key Developments

        21.11.6. SWOT Analysis

    21.12. Vieworks Co., Ltd.

        21.12.1. Company Overview

        21.12.2. Reagent Portfolio

        21.12.3. Key Strategies

        21.12.4. Regional Presence

        21.12.5. Key Developments

        21.12.6. SWOT Analysis

22. Appendix

23. Definitions of Analytical Frameworks

24. Sources and References

Table 01: Global Market Volume (Units), by Modality, 2018 to 2033

Table 02: Global Market Value (US$ Mn), by Modality, 2018 to 2033

Table 03: Global Market Volume (Units), by Reagent, 2018 to 2033

Table 04: Global Market Value (US$ Mn), by Reagent, 2018 to 2033

Table 05: Global Market Volume (Units), by Application, 2018 to 2033

Table 06: Global Market Value (US$ Mn), by Application, 2018 to 2033

Table 07: Global Market Volume (Units), by End User, 2018 to 2033

Table 08: Global Market Value (US$ Mn), by End User, 2018 to 2033

Table 09: Global Market Volume (Units), by Region, 2018 to 2033

Table 10: Global Market Value (US$ Mn), by Region, 2018 to 2033

Table 11: North America Market Volume (Units), by Modality, 2018 to 2033

Table 12: North America Market Value (US$ Mn), by Modality, 2018 to 2033

Table 13: North America Market Volume (Units), by Reagent, 2018 to 2033

Table 14: North America Market Value (US$ Mn), by Reagent, 2018 to 2033

Table 15: North America Market Volume (Units), by Application, 2018 to 2033

Table 16: North America Market Value (US$ Mn), by Application, 2018 to 2033

Table 17: North America Market Volume (Units), by End User, 2018 to 2033

Table 18: North America Market Value (US$ Mn), by End User, 2018 to 2033

Table 19: North America Market Volume (Units), by Country, 2018 to 2033

Table 20: North America Market Value (US$ Mn), by Country, 2018 to 2033

Table 21: Europe Market Volume (Units), by Modality, 2018 to 2033

Table 22: Europe Market Value (US$ Mn), by Modality, 2018 to 2033

Table 23: Europe Market Volume (Units), by Reagent, 2018 to 2033

Table 24: Europe Market Value (US$ Mn), by Reagent, 2018 to 2033

Table 25: Europe Market Volume (Units), by Application, 2018 to 2033

Table 26: Europe Market Value (US$ Mn), by Application, 2018 to 2033

Table 27: Europe Market Volume (Units), by End User, 2018 to 2033

Table 28: Europe Market Value (US$ Mn), by End User, 2018 to 2033

Table 29: Europe Market Volume (Units), by Country, 2018 to 2033

Table 30: Europe Market Value (US$ Mn), by Country, 2018 to 2033

Table 31: East Asia Market Volume (Units), by Modality, 2018 to 2033

Table 32: East Asia Market Value (US$ Mn), by Modality, 2018 to 2033

Table 33: East Asia Market Volume (Units), by Reagent, 2018 to 2033

Table 34: East Asia Market Value (US$ Mn), by Reagent, 2018 to 2033

Table 35: East Asia Market Volume (Units), by Application, 2018 to 2033

Table 36: East Asia Market Value (US$ Mn), by Application, 2018 to 2033

Table 37: East Asia Market Volume (Units), by End User, 2018 to 2033

Table 38: East Asia Market Value (US$ Mn), by End User, 2018 to 2033

Table 39: East Asia Market Volume (Units), by Country, 2018 to 2033

Table 40: East Asia Market Value (US$ Mn), by Country, 2018 to 2033

Table 41: South Asia Market Volume (Units), by Modality, 2018 to 2033

Table 42: South Asia Market Value (US$ Mn), by Modality, 2018 to 2033

Table 43: South Asia Market Volume (Units), by Reagent, 2018 to 2033

Table 44: South Asia Market Value (US$ Mn), by Reagent, 2018 to 2033

Table 45: South Asia Market Volume (Units), by Application, 2018 to 2033

Table 46: South Asia Market Value (US$ Mn), by Application, 2018 to 2033

Table 47: South Asia Market Volume (Units), by End User, 2018 to 2033

Table 48: South Asia Market Value (US$ Mn), by End User, 2018 to 2033

Table 49: South Asia Market Volume (Units), by Country, 2018 to 2033

Table 50: South Asia Market Value (US$ Mn), by Country, 2018 to 2033

Table 51: Latin America Market Volume (Units), by Modality, 2018 to 2033

Table 52: Latin America Market Value (US$ Mn), by Modality, 2018 to 2033

Table 53: Latin America Market Volume (Units), by Reagent, 2018 to 2033

Table 54: Latin America Market Value (US$ Mn), by Reagent, 2018 to 2033

Table 55: Latin America Market Volume (Units), by Application, 2018 to 2033

Table 56: Latin America Market Value (US$ Mn), by Application, 2018 to 2033

Table 57: Latin America Market Volume (Units), by End User, 2018 to 2033

Table 58: Latin America Market Value (US$ Mn), by End User, 2018 to 2033

Table 59: Latin America Market Volume (Units), by Country, 2018 to 2033

Table 60: Latin America Market Value (US$ Mn), by Country, 2018 to 2033

Table 61: Middle East and Africa Market Volume (Units), by Modality, 2018 to 2033

Table 62: Middle East and Africa Market Value (US$ Mn), by Modality, 2018 to 2033

Table 63: Middle East and Africa Market Volume (Units), by Reagent, 2018 to 2033

Table 64: Middle East and Africa Market Value (US$ Mn), by Reagent, 2018 to 2033

Table 65: Middle East and Africa Market Volume (Units), by Application, 2018 to 2033

Table 66: Middle East and Africa Market Value (US$ Mn), by Application, 2018 to 2033

Table 67: Middle East and Africa Market Volume (Units), by End User, 2018 to 2033

Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2018 to 2033

Table 69: Middle East and Africa Market Volume (Units), by Country, 2018 to 2033

Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2018 to 2033

Table 71: Oceania Market Volume (Units), by Modality, 2018 to 2033

Table 72: Oceania Market Value (US$ Mn), by Modality, 2018 to 2033

Table 73: Oceania Market Volume (Units), by Reagent, 2018 to 2033

Table 74: Oceania Market Value (US$ Mn), by Reagent, 2018 to 2033

Table 75: Oceania Market Volume (Units), by Application, 2018 to 2033

Table 76: Oceania Market Value (US$ Mn), by Application, 2018 to 2033

Table 77: Oceania Market Volume (Units), by End User, 2018 to 2033

Table 78: Oceania Market Value (US$ Mn), by End User, 2018 to 2033

Table 79: Oceania Market Volume (Units), by Country, 2018 to 2033

Table 80: Oceania Market Value (US$ Mn), by Country, 2018 to 2033
※参考情報

光前臨床イメージングとは、主に動物モデルを使用して光学的手法を用いて生体内の構造や機能を観察する技術です。このイメージング手法は、医学や生物学の研究において、特に新しい治療法や薬剤の効果を評価するために重要な役割を果たします。

光前臨床イメージングの主な種類には、蛍光イメージング、ルミネッセンスイメージング、近赤外線イメージング、反射型イメージングなどがあります。蛍光イメージングでは、特定の蛍光色素やタグを用いて画像を取得し、細胞や組織の特定の部分を可視化します。ルミネッセンスイメージングは、発光反応によって生じた光を捉える方法で、特に細胞内の生物学的過程をリアルタイムで観察できます。近赤外線イメージングは、組織の深部に光を透過させ、血流や酸素飽和度の変化を評価するのに適しています。反射型イメージングでは、組織表面での光の反射を利用して形態を観察します。

これらの技術は、医薬品の開発やがん治療の研究、神経科学、心血管研究、さらには再生医療など、さまざまな用途に応じて活用されています。例えば、がん研究では腫瘍細胞の特定のマーカーを可視化し、腫瘍の成長や転移をリアルタイムで追跡することが可能です。また、神経科学の分野では、神経細胞内のカルシウム濃度の変化を観察することで、脳内の電気活動を詳細に調べることができます。

光前臨床イメージングは、非侵襲的であるため、動物モデルに対しても安全に適用できることが大きな魅力です。従来のイメージング技術と比較して、属性が明確で迅速にデータを取得できるため、さまざまな研究ニーズに応じた柔軟なアプローチが可能になります。また、蓄積されたデータは、他の研究と組み合わせて解析することで、新たな知見を得る手助けとなります。

これに関連した技術としては、光学的なプローブの開発や、コンピュータビジョンアルゴリズムの進化があります。光学的プローブは、特定の生物学的マーカーや分子に特異的に結合することで、対象の可視化を可能にします。これらのプローブは、蛍光タンパク質や分子ビジュアライゼーション技術を組み合わせることで、より高い感度と特異性を持つように設計されています。

さらに、人工知能（AI）や機械学習の技術も光前臨床イメージングにおいて重要な役割を果たしています。これらの技術を活用することで、画像解析を高速化し、より詳細な情報を引き出すことが可能になります。たとえば、腫瘍の自動識別や進行度の評価、あるいは薬剤の効果を定量的に評価するためのデータ分析が行われています。

最近の研究では、光前臨床イメージングがマルチモーダルイメージングへと進化してきている傾向があります。これは、異なるイメージング技術を組み合わせることで、より多角的な情報を得ることを目的としています。光イメージングとMRI（磁気共鳴画像法）やCT（コンピュータ断層撮影）などの他のイメージング技術を融合させることにより、情報の精度と詳細度を向上させ、複雑な生態系の課題に対する理解を深めることが可能です。

加えて、薬剤の新規開発においても、光前臨床イメージングは非常に重要です。薬剤の動態をリアルタイムで追跡することにより、安全性や効果を評価する際に非常に貴重なデータを提供します。その結果、より効率的に開発スケジュールを短縮し、新しい治療法を迅速に患者に届けることが可能になります。

光前臨床イメージングは、急速に進化している分野であり、今後の研究においてますます重要な役割を果たすと考えられています。この技術のさらなる発展により、より多くの生命科学分野の狭間にある疑問を解決し、疾患の理解や治療法の改善に寄与することが期待されています。光前臨床イメージングは、生命科学の研究における新しい時代を迎える鍵となる技術です。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血液透析のグローバル市場2023～2033：サービス、薬剤、消耗品、機器
  • 防塵剤のグローバル市場2023～2033（~2033）：湿式防塵剤、乾式防塵剤
  • 標準型バルーンカテーテルのグローバル市場2023～2033：ポリウレタン、ナイロン
  • 尿流（ウロダイナミクス/UD）測定器のグローバル市場2023～2033：尿流測定器、外来尿流測定器、膀胱内圧計、ビデオ尿流測定器、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(FACT23AP099 )"光前臨床イメージングのグローバル市場2023～2033：生物発光/蛍光イメージングシステム、スタンドアロン型蛍光イメージングシステム、光学＋X線／光学＋CT" (英文：Optical Preclinical Imaging Market Analysis By Reagent (Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents), By Application (Research & Development, Drug Discovery), By End User (Pharma & Biotech Companies, Research Institutes), By Modality & Region - Global Market Insights 2023 to 2033)はFactMR社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。